Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors

Behavioural Pharmacology

Volumn 22, Issue 4, 2011, Pages 335-346

  Hampson, Robert E ^a   Sweatt, Andrew J ^a   Goonawardena, Anushka V ^a   Song, Dong ^b   Chan, Rosa H M ^b   Marmarelis, Vasilis Z ^b   Berger, Theodore W ^b   Deadwyler, Sam A ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b University of Southern California   (United States)

Author keywords

cannabinoids; endocannabinoids; hippocampal ensembles; intrahippocampal infusion; memory encoding; patterned stimulation; rat

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; MEMORY; NONHUMAN; RAT;

ACTION POTENTIALS; ANIMALS; BENZAMIDES; BENZOXAZINES; BIPHENYL COMPOUNDS; CA1 REGION, HIPPOCAMPAL; CANNABINOIDS; CARBAMATES; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; HIPPOCAMPUS; INJECTIONS; MALE; MEMORY; MORPHOLINES; NAPHTHALENES; NEURONS; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1;

EID: 79960697337     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283473bfd     Document Type: Article

References (48)

1. Abush H, Akirav I (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20:1126-1138.
2. Auclair N, Otani S, Soubrie P, Crepel F (2000). Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83:3287-3293. (Pubitemid 30408863)
3. Ballmaier M, Bortolato M, Rizzetti C, Zoli M, Gessa G, Heinz A, Spano P (2007). Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. Neuropsychopharmacology 32:2098-2107. (Pubitemid 47417693)
4. Berger TW, Hampson RE, Song D, Goonawardena A, Marmarelis VZ, Deadwyler SA (2011). A cortical neural prosthesis for restoring and enhancing memory. J Neural Eng 2011 (in press).
5. Black MD, Varty GB, Arad M, Barak S, De LA, Boulay D, et al. (2009). Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology (Berl) 202:385-396.
6. Borowski BJ, Stevens R, Black M, Senyah Y, Rogacki N, Giardino O, et al. (2005). AVE1625: a cannabinoid CB1 antagonist, as a co-treatment for schizophrenia: Improvement in cognitive function and reduction of antipsy-chotic side effects in animal models. Neuropsychopharmacology 30:S116.
7. Bubenikova-Valesova V, Horacek J, Vrajova M, Hoschl C (2008). Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32:1014-1023. (Pubitemid 351756510)
8. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, et al. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594-608. (Pubitemid 40409699)
9. Deadwyler SA, Hampson RE (1997). The significance of neural ensemble codes during behavior and cognition. In: Cowan WM, Shooter EM, Stevens CF, Thompson RF, editors. Annual review of neuroscience. Vol. 20. Palo Alto, CA: Annual Reviews, Inc.; pp. 217-244. (Pubitemid 27106381)
10. Deadwyler SA, Hampson RE (2004). Differential but complementary mnemonic functions of the hippocampus and subiculum. Neuron 42:465-476. (Pubitemid 38610144)
11. Deadwyler SA, Hampson RE (2006). Temporal coupling between subicular and hippocampal neurons underlies retention of trial-specific events. Behav Brain Res 174:272-280. (Pubitemid 44585074)
12. Deadwyler SA, Hampson RE (2008). Endocannabinoids modulate encoding of sequential memory in the rat hippocampus. Psychopharmacology (Berl) 198:577-586.
13. Deadwyler SA, Bunn T, Hampson RE (1996). Hippocampal ensemble activity during spatial delayed-nonmatch-to-sample performance in rats. J Neurosci 16:354-372. (Pubitemid 26010722)
14. Deadwyler SA, Goonawardena AV, Hampson RE (2007). Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes. Behav Pharmacol 18:571-580. (Pubitemid 47356383)
15. Falenski KW, Blair RE, Sim-Selley LJ, Martin BR, DeLorenzo RJ (2007). Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146:1232-1244. (Pubitemid 46694119)
16. Foldy C, Neu A, Jones MV, Soltesz I (2006). Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26:1465-1469. (Pubitemid 43237017)
17. Fortin DA, Trettel J, Levine ES (2004). Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92:2105-2112. (Pubitemid 39298667)
18. Gaisler-Salomon I,Weiner I (2003). Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology (Berl) 166:333-342. (Pubitemid 36469935)
19. Gaisler-Salomon I, Diamant L, Rubin C, Weiner I (2008). Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology (Berl) 196:255-267.
20. Glickfeld LL, Scanziani M (2006). Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9:807-815.
21. Goonawardena AV, Riedel G, Hampson RE (2010a). Cannabinoids alter spontaneous firing, bursting, and cell synchrony of hippocampal principal cells. Hippocampus 2011 [Epub ahead of print]. doi: 10.1002/hipo.20769
22. Goonawardena AV, Robinson L, Riedel G, Hampson RE (2010b). Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure. Hippocampus 20:1083-1094.
23. Hajos M, Hoffmann WE, Kocsis B (2008). Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 63:1075-1083.
24. Hampson RE, Deadwyler SA (1998). Role of cannabinoid receptors in memory storage. Neurobiol Dis 5:474-482. (Pubitemid 29075846)
25. Hampson RE, Deadwyler SA (1999). Cannabinoids, hippocampal function and memory. Life Sci 65:715-723. (Pubitemid 29362777)
26. Hampson RE, Deadwyler SA (2000). Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20:8932-8942.
27. Hampson RE, Simeral JD, Deadwyler SA (1999). Distribution of spatial and nonspatial information in dorsal hippocampus. Nature 402:610-614.
28. Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA (2003). Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippo-campal neurons. Hippocampus 13:543-556. (Pubitemid 36958279)
29. Hampson RE, Simeral JD, Deadwyler SA (2008). Neural population recording in behaving animals: constituents of the neural code for behavior. In: Holscher C, Munk MH, editors. Neural population encoding. Cambridge, UK: Cambridge University Press; pp. 74-94.
30. Hampson RE, Miller F, Palchik G, Deadwyler SA (2011a). Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharm. 60:944-952.
31. Hampson RE, Simeral JD, Berger TW, Song D, Chan RHM, Deadwyler SA (2011b). Cognitively relevant recording in hippocampus: beneficial feedback of ensemble codes in a closed loop paradigm. In: Vertes RP, Stackman RW, editors. Electrophysiological recording techniques. New York: Humana Press; pp. 215-240.
32. Heyser CJ, Hampson RE, Deadwyler SA (1993). The effects of delta-9-THC on delayed match to sample performance in rats: alterations in short-term memory produced by changes in task specific firing of hippocampal neurons. J Pharmacol Exp Ther 264:294-307. (Pubitemid 23309216)
33. Janero DR, Makriyannis A (2009). Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs 14:43-65.
34. Karanian DA, Brown QB, Makriyannis A, Kosten TA, Bahr BA (2005). Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. J Neurosci 25:7813-7820. (Pubitemid 41208653)
35. Lichtman AH (2000). SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 404:175-179.
36. Lichtman AH, Dimen KR, Martin BR (1995). Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharma-cology (Berl) 119:282-290.
37. Lundqvist T (2005). Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81:319-330. (Pubitemid 40807130)
38. Manwell LA, Satvat E, Lang ST, Allen CP, Leri F, Parker LA (2009). FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats. Pharmacol Biochem Behav 94:154-162.
39. Micheau J, Riedel G, Roloff EL, Inglis J, Morris RG (2004). Reversible hippocampal inactivation partially dissociates how and where to search in the water maze. Behav Neurosci 118:1022-1032. (Pubitemid 39346507)
40. Moreira FA, Grieb M, Lutz B (2009). Central side effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab 23:133-144.
41. Rao CR (2002). Linear statistical inference and its applications. New York, NY: Wiley.
42. Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A (1999). Enhancement of memory in cannabinoid CB1 receptor knockout mice. Eur J Pharmacol 379:R1-R2. (Pubitemid 29492956)
43. Shen M, Piser TM, Seybold VS, Thayer SA (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334. (Pubitemid 26243028)
44. Stevens J (2002). Applied multivariate statistics for the social sciences. Hillsdale: Lawrence Erlbaum Associates.
45. Takahashi RN, Pamplona FA, Fernandes MS (2005). The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 380:270-275. (Pubitemid 40616094)
46. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P (1996). Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology (Berl) 126:165-172. (Pubitemid 26246767)
47. Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP, et al. (2003). The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138:544-553. (Pubitemid 36315302)
48. Watson DJ, Stanton ME (2009). Intrahippocampal administration of an NMDA-receptor antagonist impairs spatial discrimination reversal learning in weanling rats. Neurobiol Learn Mem 92:89-98.